Vifor Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VIFOR PHARMA, and when can generic versions of VIFOR PHARMA drugs launch?
VIFOR PHARMA has one approved drug.
There are thirteen US patents protecting VIFOR PHARMA drugs.
There are one hundred and seventy-four patent family members on VIFOR PHARMA drugs in twenty-seven countries and thirty-two supplementary protection certificates in eighteen countries.
Drugs and US Patents for Vifor Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-004 | Oct 2, 2023 | DISCN | Yes | No | 8,337,824 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-004 | Oct 2, 2023 | DISCN | Yes | No | 8,778,324 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | RX | Yes | Yes | 8,216,560 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Vifor Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | 8,889,115 | ⤷ Try a Trial |
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-004 | Oct 2, 2023 | 8,475,780 | ⤷ Try a Trial |
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-001 | Oct 21, 2015 | 8,475,780 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Vifor Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2005228696 | ⤷ Try a Trial |
United Kingdom | 2475657 | ⤷ Try a Trial |
South Korea | 20110063647 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Vifor Pharma Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2365988 | PA2018004 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: PATIROMERO, SORBITOLIO IR KALCIO KOMPLEKSAS IR JO DRUSKOS; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
1732523 | 300925 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: PATIROMER EN ALLE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/17/1179/001-009 20170721 |
2957286 | 122018000145 | Germany | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.